Share on StockTwits
 

Analysts’ price target changes for Wednesday, February 26th:

Avago Technologies (NASDAQ:AVGO) had its target price boosted by Jefferies Group to $60.00. The firm currently has a hold rating on the stock.

Chicago Bridge & Iron Company NV (NYSE:CBI) had its target price raised by UBS AG to $89.00. UBS AG currently has a buy rating on the stock.

Endurance International Group Hldgs (NASDAQ:EIGI) had its price target boosted by UBS AG to $22.00. UBS AG currently has a buy rating on the stock.

Expeditors International of Washington (NASDAQ:EXPD) had its target price raised by Credit Suisse from $44.00 to $80.00. Credit Suisse currently has a buy rating on the stock.

Forest Oil Corp. (NYSE:FST) had its target price cut by Goldman Sachs to $2.50. The firm currently has a sell rating on the stock.

Forest Oil Corp. (NYSE:FST) had its target price lowered by Ladenburg Thalmann from $7.00 to $4.00. They currently have a buy rating on the stock.

Intu Properties PLC (LON:INTU) had its target price boosted by Cantor Fitzgerald Europe from GBX 327 ($5.44) to GBX 350 ($5.82). The firm currently has a hold rating on the stock.

InterMune (NASDAQ:ITMN) had its target price boosted by Goldman Sachs to $40.00.

Jazz Pharmaceuticals Plc (NASDAQ:JAZZ) had its target price boosted by UBS AG to $195.00. The firm currently has a buy rating on the stock.

Fifth & Pacific Companies (NASDAQ:KATE) had its target price increased by Telsey Advisory Group from $38.00 to $40.00. They currently have a not rated rating on the stock.

Mazor Robotics Ltd. – American Depositary Shares (NASDAQ:MZOR) had its price target boosted by Ladenburg Thalmann from $20.75 to $27.50. They currently have a buy rating on the stock.

Questcor Pharmaceuticals (NASDAQ:QCOR) had its target price boosted by Ladenburg Thalmann from $84.00 to $85.00. The firm currently has a buy rating on the stock.

Unit (NYSE:UNT) had its price target raised by Cowen and Company from $58.00 to $67.00. The firm currently has a market perform rating on the stock.

United Therapeutics Corp. (NASDAQ:UTHR) had its target price cut by Ladenburg Thalmann from $138.00 to $135.00. Ladenburg Thalmann currently has a buy rating on the stock.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.